Search research articles
Contact Us
Filters
Showing results (151-160 of 460) with videos related to
Page
of 46
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 16, 2020
Myeloablative versus Reduced-Intensity Hematopoietic Cell Transplantation in Myelodysplastic Syndromes: Systematic Review and Meta-analysis
Armin Rashidi, Mohamad A Meybodi, Wenhao Cao, et al.
Transplantation and Cellular Therapy
|
January 4, 2026
Financial toxicity in a phase I/II trial of LV20.19 CAR-T cell for B-cell malignancies a longitudinal, qualitative study
Elizabeth Aughey, Nirav N Shah, Cecilia J Hillard, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 28, 2026
An Evaluation of Ibrutinib and Ixazomib in Patients With Relapsed/Refractory Mantle Cell Lymphoma: PrE0404
Jonathon B Cohen, Craig A Portell, Mehdi Hamadani, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 24, 2018
Impact of Obesity on Clinical Outcomes of Elderly Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myeloid Malignancies
Ensi Voshtina, Aniko Szabo, Mehdi Hamadani, et al.
Transplantation and Cellular Therapy
|
June 19, 2026
Reduced Toxicity Conditioning Allogeneic Hematopoietic Cell Transplantation with Once Daily Intravenous Busulfan for Relapsed/Refractory Lymphoma - a Phase II Study
Carl Shultz, Shreyas Shirodkar, Chelby Wakefield, et al.
Journal of Clinical Apheresis
|
October 1, 2019
An updated single center experience with plerixafor and granulocyte colony-stimulating factor for stem cell mobilization in light chain amyloidosis
Talha Badar, Binod Dhakal, Aniko Szabo, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 3, 2025
Indirect Comparison of Epcoritamab Versus Axicabtagene Ciloleucel in Chimeric Antigen Receptor T-Cell-Eligible and -Naive Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Gilles Salles, Christopher P Fox, Mehdi Hamadani, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 24, 2013
Predictors and impact of thirty-day readmission on patient outcomes and health care costs after reduced-toxicity conditioning allogeneic hematopoietic cell transplantation
Sherri Rauenzahn, Quoc Truong, Aaron Cumpston, et al.
British Journal of Haematology
|
September 17, 2013
Gemtuzumab ozogamicin for treatment of newly diagnosed acute myeloid leukaemia: a systematic review and meta-analysis
Mohamed A Kharfan-Dabaja, Mehdi Hamadani, Tea Reljic, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 7, 2022
Impact of Chronic Kidney Disease and Acute Kidney Injury on Safety and Outcomes of CAR T-Cell Therapy in Lymphoma Patients
Gulrayz Ahmed, Bhavna Bhasin-Chhabra, Aniko Szabo, et al.
Page
of 46
Search research articles
Search
Showing results (151-160 of 460) with videos related to
Sort By:
Page
of 46
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 16, 2020
Myeloablative versus Reduced-Intensity Hematopoietic Cell Transplantation in Myelodysplastic Syndromes: Systematic Review and Meta-analysis
Armin Rashidi, Mohamad A Meybodi, Wenhao Cao, et al.
Transplantation and Cellular Therapy
|
January 4, 2026
Financial toxicity in a phase I/II trial of LV20.19 CAR-T cell for B-cell malignancies a longitudinal, qualitative study
Elizabeth Aughey, Nirav N Shah, Cecilia J Hillard, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 28, 2026
An Evaluation of Ibrutinib and Ixazomib in Patients With Relapsed/Refractory Mantle Cell Lymphoma: PrE0404
Jonathon B Cohen, Craig A Portell, Mehdi Hamadani, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 24, 2018
Impact of Obesity on Clinical Outcomes of Elderly Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myeloid Malignancies
Ensi Voshtina, Aniko Szabo, Mehdi Hamadani, et al.
Transplantation and Cellular Therapy
|
June 19, 2026
Reduced Toxicity Conditioning Allogeneic Hematopoietic Cell Transplantation with Once Daily Intravenous Busulfan for Relapsed/Refractory Lymphoma - a Phase II Study
Carl Shultz, Shreyas Shirodkar, Chelby Wakefield, et al.
Journal of Clinical Apheresis
|
October 1, 2019
An updated single center experience with plerixafor and granulocyte colony-stimulating factor for stem cell mobilization in light chain amyloidosis
Talha Badar, Binod Dhakal, Aniko Szabo, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 3, 2025
Indirect Comparison of Epcoritamab Versus Axicabtagene Ciloleucel in Chimeric Antigen Receptor T-Cell-Eligible and -Naive Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Gilles Salles, Christopher P Fox, Mehdi Hamadani, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 24, 2013
Predictors and impact of thirty-day readmission on patient outcomes and health care costs after reduced-toxicity conditioning allogeneic hematopoietic cell transplantation
Sherri Rauenzahn, Quoc Truong, Aaron Cumpston, et al.
British Journal of Haematology
|
September 17, 2013
Gemtuzumab ozogamicin for treatment of newly diagnosed acute myeloid leukaemia: a systematic review and meta-analysis
Mohamed A Kharfan-Dabaja, Mehdi Hamadani, Tea Reljic, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 7, 2022
Impact of Chronic Kidney Disease and Acute Kidney Injury on Safety and Outcomes of CAR T-Cell Therapy in Lymphoma Patients
Gulrayz Ahmed, Bhavna Bhasin-Chhabra, Aniko Szabo, et al.
Page
of 46